Leanne Te Karu

746 total citations
25 papers, 467 citations indexed

About

Leanne Te Karu is a scholar working on Nephrology, Surgery and General Health Professions. According to data from OpenAlex, Leanne Te Karu has authored 25 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nephrology, 6 papers in Surgery and 6 papers in General Health Professions. Recurrent topics in Leanne Te Karu's work include Gout, Hyperuricemia, Uric Acid (16 papers), Case Reports on Hematomas (6 papers) and Primary Care and Health Outcomes (5 papers). Leanne Te Karu is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (16 papers), Case Reports on Hematomas (6 papers) and Primary Care and Health Outcomes (5 papers). Leanne Te Karu collaborates with scholars based in New Zealand, United States and Australia. Leanne Te Karu's co-authors include Nicola Dalbeth, Linda Bryant, Bruce Arroll, William J. Taylor, Doone Winnard, Peter Gow, Barry Gribben, Graham S. Jackson, Simon Thornley and C. Raina Elley and has published in prestigious journals such as Nature Reviews Rheumatology, Lara D. Veeken and BMJ Open.

In The Last Decade

Leanne Te Karu

22 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leanne Te Karu New Zealand 11 331 163 133 65 42 25 467
Viviane Angelina de Souza Brazil 9 141 0.4× 56 0.3× 74 0.6× 37 0.6× 36 0.9× 18 507
Arsalan N. Habib United States 11 166 0.5× 159 1.0× 23 0.2× 20 0.3× 14 0.3× 11 405
Katherine L. Hull United Kingdom 10 232 0.7× 106 0.7× 13 0.1× 11 0.2× 28 0.7× 27 501
Anuja Shah United States 9 318 1.0× 46 0.3× 52 0.4× 49 0.8× 18 0.4× 18 463
Ana Vigil Spain 11 285 0.9× 85 0.5× 19 0.1× 27 0.4× 7 0.2× 18 391
Shiva Seirafian Iran 10 184 0.6× 100 0.6× 22 0.2× 73 1.1× 30 0.7× 39 391
Bülent Erbay Türkiye 11 97 0.3× 78 0.5× 19 0.1× 9 0.1× 45 1.1× 24 565
John N. Mecchella United States 8 68 0.2× 78 0.5× 70 0.5× 31 0.5× 15 0.4× 19 278
Terry King‐Wing China 11 208 0.6× 39 0.2× 18 0.1× 19 0.3× 39 0.9× 18 360
Cynda Ann Johnson United States 8 79 0.2× 49 0.3× 13 0.1× 10 0.2× 17 0.4× 15 373

Countries citing papers authored by Leanne Te Karu

Since Specialization
Citations

This map shows the geographic impact of Leanne Te Karu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leanne Te Karu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leanne Te Karu more than expected).

Fields of papers citing papers by Leanne Te Karu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leanne Te Karu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leanne Te Karu. The network helps show where Leanne Te Karu may publish in the future.

Co-authorship network of co-authors of Leanne Te Karu

This figure shows the co-authorship network connecting the top 25 collaborators of Leanne Te Karu. A scholar is included among the top collaborators of Leanne Te Karu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leanne Te Karu. Leanne Te Karu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leask, Megan, Tony R. Merriman, Thomas Bardin, et al.. (2025). Hyperuricaemia and gout in the Pacific. Nature Reviews Rheumatology. 21(4). 197–210. 9 indexed citations
2.
Crocket, Hamish, Timothy Kenealy, Rinki Murphy, et al.. (2025). Impact of a clinical diabetes specialist mentoring programme on type 2 diabetes management among nurses in primary care: a qualitative study. Journal of Primary Health Care. 18(1). 71–74.
3.
Chepulis, Lynne, Mark Rodrigues, Han Ming Gan, et al.. (2025). Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New Zealand. BMC Health Services Research. 25(1). 433–433. 3 indexed citations
4.
Cassim, Shemana, Penny Clark, Rāwiri Keenan, et al.. (2024). General practitioner and nurse experiences of type 2 diabetes management and prescribing in primary care: a qualitative review following the introduction of funded SGLT2i/GLP1RA medications in Aotearoa New Zealand. Primary Health Care Research & Development. 25. e34–e34. 2 indexed citations
6.
Dalbeth, Nicola, Leanne Te Karu, & Lisa K. Stamp. (2024). Gout and its management. Internal Medicine Journal. 54(5). 716–723. 4 indexed citations
7.
Kleinstäuber, Maria, et al.. (2023). The Big Picture: Patient Drawings of Gout and Their Relationship to Illness Perceptions and Stigma. The Journal of Rheumatology. 51(2). 203–205. 1 indexed citations
8.
Stamp, Lisa K., et al.. (2023). Colchicine: the good, the bad, the ugly and how to minimize the risks. Lara D. Veeken. 63(4). 936–944. 26 indexed citations
9.
Karu, Leanne Te, Matire Harwood, Linda Bryant, Timothy Kenealy, & Bruce Arroll. (2021). Compounding inequity: a qualitative study of gout management in an urban marae clinic in Auckland. Journal of Primary Health Care. 13(1). 27–35. 9 indexed citations
10.
Karu, Leanne Te, Matire Harwood, Bruce Arroll, Linda Bryant, & Timothy Kenealy. (2021). The inequity of access to health: a case study of patients with gout in one general practice.. PubMed. 134(1543). 51–58. 6 indexed citations
11.
Karu, Leanne Te, Nicola Dalbeth, & Lisa K. Stamp. (2021). Inequities in people with gout: a focus on Māori (Indigenous People) of Aotearoa New Zealand. Therapeutic Advances in Musculoskeletal Disease. 13. 1759720X211028007–1759720X211028007. 12 indexed citations
12.
Karu, Leanne Te, et al.. (2020). Gender and Ethnic Inequities in Gout Burden and Management. Rheumatic Disease Clinics of North America. 46(4). 693–703. 28 indexed citations
13.
Dalbeth, Nicola, et al.. (2020). The impact of the illness label ‘gout’ on illness and treatment perceptions in Māori (Indigenous New Zealanders). BMC Rheumatology. 4(1). 23–23. 2 indexed citations
14.
Karu, Leanne Te, Timothy Kenealy, Linda Bryant, Bruce Arroll, & Matire Harwood. (2020). The long shadow of inequity for Māori with gout. 9(2). 2 indexed citations
15.
Karu, Leanne Te, Linda Bryant, Matire Harwood, & Bruce Arroll. (2018). Achieving health equity in Aotearoa New Zealand: the contribution of medicines optimisation. Journal of Primary Health Care. 10(1). 11–15. 18 indexed citations
16.
Norris, Pauline, et al.. (2015). Impact of prescription charges on people living in poverty: A qualitative study. Research in Social and Administrative Pharmacy. 12(6). 893–902. 27 indexed citations
17.
Winnard, Doone, Cameron Wright, William J. Taylor, et al.. (2012). National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Lara D. Veeken. 51(5). 901–909. 147 indexed citations
18.
Martini, Nataly, et al.. (2012). Living With Gout in New Zealand. JCR Journal of Clinical Rheumatology. 18(3). 125–129. 35 indexed citations
19.
Jackson, Gary, Craig Wright, Simon Thornley, et al.. (2012). Potential unmet need for gout diagnosis and treatment: capture-recapture analysis of a national administrative dataset. Lara D. Veeken. 51(10). 1820–1824. 27 indexed citations
20.
Dalbeth, Nicola, Meaghan E House, Anne Horne, et al.. (2012). The experience and impact of gout in Māori and Pacific people: a prospective observational study. Clinical Rheumatology. 32(2). 247–251. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026